It was also reported that high levels of TG2 in glioma cells conferred resistance preferentially against doxorubicin, while failing to respond to several other chemotherapeutics, indicating that TG2-mediated resistance can be drug-specific [128]. This evidence concerns the gene TGM2 and glioma.